| Primary information |
|---|
| ID | 1130 |
| Peptide Name | CKS-17 |
| Sequence | LQNRRGLDLLFLKEGGLC |
| Length | 18 |
| Chirality | L |
| N-terminal Modification | None |
| C-terminal Modification | None |
| Chemical Modification | None |
| Linear/ Cyclic | Linear |
| Nature | Protein Derived |
| Source of Origin | murine leukemia virus (MLV) |
| Target | TNF-α |
| Mechanism of Action | Significantly reduces the mRNA levels of IL-17C, TNF-α, IL-6 and CXCL2 |
| In vitro/In vivo | Both |
| Cell Line | Acute allergic contact dermatitis model and TPA toxic eczema model |
| Inhibition Concentartion | NA |
| In vivo Model | C57BL/6 mice and BALB/CJ mice |
| Assay | NA |
| Lethal Dose | NA |
| Combination Therapy | NA |
| Pubmed ID | 24245569 |
| Year of Publication | 2013 |
| 3-D Structure |  View in Jmol or Download Structure |
